Dr. Sinha graduated from Department of Immunopathology after successfully completing thesis work on developing monoclonal antibodies for serodiagnosis of Kala-azar. After training and becoming a faculty at Baylor College of Medicine, Houston, Texas, he joined as an Associate Professor in the Department of Biochemistry and Molecular Biology at Penn State College of Medicine, Hershey, Pennsylvania. He joined as a corporate faculty at HU in 2015. He has hosted several HU students seeking internships, in his laboratory at Penn State Cancer Institute.
Teaching & Research Interests:
Dr. Sinha has taught a variety of courses including Biology of Cancer, Cellular and Molecular Basis of Medical Practice, Pharmacology, Chemical Carcinogenesis and Chemoprevention, Cancer Biotechnology, and Problem Based Learning for Medical Students. He has a special interest in biomarkers and expertise in mechanisms of cancer chemoprevention and therapy, with special training in the in vitro and in vivo models for breast and prostate cancer. He has conducted clinical studies to uncover selenium-responsive proteins in healthy men at risk for prostate cancer, and protein markers of disease progression in breast and prostate cancer patients. Additionally, he has used translational anti-aging strategy for cancer prevention by dietary methionine restriction. More recently, he has developed expertise in the field of Systems Biology and its application in cancer biomarkers and therapeutic targets.
Courses Taught at HU:
Instrumentation in Biotechnology (BTECH550)
Cancer Biotechnology (BTECH630)
Research Methodology and Writing (GRAD695)
Ph.D. in Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
MS in Biophysics, Panjab University, Chandigarh, India; BS in Panjab University, Chandigarh, India.